[Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
Papadakis
E
E
Service de pneumologie, Hôpital Sotiria, Athènes.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D020360:Neoadjuvant Therapy; D011013:Pneumonectomy; D011182:Postoperative Care; D011879:Radiotherapy Dosage; D012307:Risk Factors; D013997:Time Factors
D000970:Antineoplastic Agents
Traitement adjuvant des stades précoces de cancers bronchiques non à petites cellules (CBNPC).